Publicaciones en las que colabora con Maria Angeles Muñoz Fernandez (25)

2019

  1. Prognostic factors of a lower CD4/CD8 ratio in long term viral suppression HIV infected children

    PLoS ONE, Vol. 14, Núm. 8

  2. Sociodemographic changes and trends in the rates of new perinatal HIV diagnoses and transmission in Spain from 1997 to 2015

    PLoS ONE, Vol. 14, Núm. 10

2018

  1. Role of HIV in the desire of procreation and motherhood in women living with HIV in Spain: A qualitative approach

    BMC Women's Health, Vol. 18, Núm. 1

  2. Sleep Profile and Self-Reported Neuropsychiatric Symptoms in Vertically HIV-Infected Adolescents on cART

    Journal of Pediatric Infectious Diseases, Vol. 13, Núm. 4, pp. 300-307

2017

  1. Low Bone Mineral Density in Vertically HIV-infected Children and Adolescents: Risk Factors and the Role of T-cell Activation and Senescence

    Pediatric Infectious Disease Journal

  2. New diagnoses of human immunodeficiency virus infection in the Spanish pediatric HIV Cohort (CoRISpe) from 2004 to 2013

    Medicine (United States), Vol. 96, Núm. 39

2016

  1. Disease disclosure, treatment adherence, and behavioural profile in a cohort of vertically acquired HIV-infected adolescents. NeuroCoRISpeS study

    AIDS Care - Psychological and Socio-Medical Aspects of AIDS/HIV, Vol. 28, Núm. 1, pp. 124-130

2015

  1. Cardiac function in vertically HIV-infected children and adolescents in the era of highly active antiretroviral therapy

    Pediatric Infectious Disease Journal, Vol. 34, Núm. 5, pp. e125-e131

  2. Lipid and glucose alterations in perinatally-acquired HIV-infected adolescents and young adults

    BMC Infectious Diseases, Vol. 15, Núm. 1

2014

  1. Aspectos psicosociales en una cohorte de adolescentes con infección por el virus de la inmunodeficiencia humana por transmisión vertical. NeuroCoRISpeS

    Enfermedades Infecciosas y Microbiologia Clinica, Vol. 32, Núm. 10, pp. 631-637

2013

  1. The CD4/CD8 ratio as a marker T-cell activation, senescence and activation/exhaustion in treated HIV-infected children and young adults

    AIDS, Vol. 27, Núm. 9, pp. 1513-1516

2012

  1. High Drug Resistance Prevalence among Vertically HIV-Infected Patients Transferred from Pediatric Care to Adult Units in Spain

    PLoS ONE, Vol. 7, Núm. 12

  2. High prevalence of X4/DM-tropic variants in children and adolescents infected with HIV-1 by vertical transmission

    Pediatric Infectious Disease Journal, Vol. 31, Núm. 10, pp. 1048-1052

  3. Potent and sustained antiviral response of raltegravir-based highly active antiretroviral therapy in HIV type 1-infected children and adolescents

    Pediatric Infectious Disease Journal, Vol. 31, Núm. 3, pp. 273-277

2011

  1. Causes of death in pediatric patients vertically infected by the human immunodeficiency virus type 1 in Madrid, Spain, from 1982 to mid-2009

    Pediatric Infectious Disease Journal, Vol. 30, Núm. 6, pp. 495-500

  2. Drug resistance prevalence and HIV-1 variant characterization in the naive and pretreated HIV-1-infected paediatric population in Madrid, Spain

    Journal of Antimicrobial Chemotherapy, Vol. 66, Núm. 10, pp. 2362-2371

  3. Etravirine-based highly active antiretroviral therapy in HIV-1-infected paediatric patients

    HIV Medicine, Vol. 12, Núm. 7, pp. 442-446

  4. First-line antiretroviral therapy with a protease inhibitor versus non-nucleoside reverse transcriptase inhibitor and switch at higher versus low viral load in HIV-infected children: An open-label, randomised phase 2/3 trial

    The Lancet Infectious Diseases, Vol. 11, Núm. 4, pp. 273-283

2010

  1. Long-term efficacy and safety of fosamprenavir in human immunodeficiency virus-infected pediatric patients

    Pediatric Infectious Disease Journal, Vol. 29, Núm. 6, pp. 563-566

  2. Opportunistic infections and organ-specific diseases in HIV-1-infected children: A cohort study (1990-2006)

    HIV Medicine, Vol. 11, Núm. 4, pp. 245-252